Seres Therapeutics (MCRB) Misses Q1 EPS by 28c

Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.28). Revenue for the quarter came in at $360 thousand.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Lockheed Martin wins $8.4B missile contract modification
• Obsidian Energy Increases Syndicated Credit Facility